BIO lobbies governments on behalf of the biotech industry on issues such as regulation and taxation. On Dec. 5, BIO named John Crowley, the founder and executive chair of Amicus Therapeutics, as its new CEO.
Earlier this year, Pfizer’s competitors AstraZeneca and Teva Pharmaceutical left the other main industry trade group, Pharmaceutical Research and Manufacturers of America.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.